BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33099473)

  • 1. The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas.
    Zaman N; Dass SS; DU Parcq P; Macmahon S; Gallagher L; Thompson L; Khorashad JS; LimbÄck-Stanic C
    Cancer Genomics Proteomics; 2020; 17(6):715-727. PubMed ID: 33099473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients.
    Jasek K; Grendar M; Stanclova A; Malicherova B; Kasubova I; Burjanivova T; Szepe P; Ciccocioppo R; Rodrigo L; Prosecky R; Kruzliak P; Plank L; Lasabova Z
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1203-1215. PubMed ID: 33044628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas.
    Gao Y; Ma P; He Y; Liu Y; Jiang Y
    Mol Neurobiol; 2016 May; 53(4):2541-9. PubMed ID: 26081139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
    Nobusawa S; Stawski R; Kim YH; Nakazato Y; Ohgaki H
    Neuropathology; 2011 Dec; 31(6):583-8. PubMed ID: 21382095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
    Glubb DM; Cerri E; Giese A; Zhang W; Mirza O; Thompson EE; Chen P; Das S; Jassem J; Rzyman W; Lingen MW; Salgia R; Hirsch FR; Dziadziuszko R; Ballmer-Hofer K; Innocenti F
    Clin Cancer Res; 2011 Aug; 17(16):5257-67. PubMed ID: 21712447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.
    Verboom MC; Kloth JSL; Swen JJ; van der Straaten T; Bovée JVMG; Sleijfer S; Reyners AKL; Mathijssen RHJ; Guchelaar HJ; Steeghs N; Gelderblom H
    Eur J Cancer; 2017 Nov; 86():226-232. PubMed ID: 29054076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in sporadic triple negative breast cancer.
    Pop LA; Cojocneanu-Petric RM; Pileczki V; Morar-Bolba G; Irimie A; Lazar V; Lombardo C; Paradiso A; Berindan-Neagoe I
    Breast; 2018 Apr; 38():30-38. PubMed ID: 29202330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.
    Silva IP; Salhi A; Giles KM; Vogelsang M; Han SW; Ismaili N; Lui KP; Robinson EM; Wilson MA; Shapiro RL; Pavlick A; Zhong J; Kirchhoff T; Osman I
    Clin Cancer Res; 2016 May; 22(10):2377-85. PubMed ID: 26631613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors.
    Puputti M; Tynninen O; Pernilä P; Salmi M; Jalkanen S; Paetau A; Sihto H; Joensuu H
    Brain Pathol; 2010 Jul; 20(4):763-70. PubMed ID: 20030644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and KIT expression in relation with microvascular density and tumor grade in supratentorial astrocytic tumors.
    Heinke T; Espiríto Santo KS; Longatto Filho A; Stavale JN
    Acta Cir Bras; 2013 Jan; 28(1):48-54. PubMed ID: 23338113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.
    Zhu X; Wang Y; Xue W; Wang R; Wang L; Zhu ML; Zheng L
    Cancer Biol Ther; 2019; 20(4):497-504. PubMed ID: 30380970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
    Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
    Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.
    Lo Iacono M; Buttigliero C; Monica V; Bollito E; Garrou D; Cappia S; Rapa I; Vignani F; Bertaglia V; Fiori C; Papotti M; Volante M; Scagliotti GV; Porpiglia F; Tucci M
    Oncotarget; 2016 Mar; 7(12):14394-404. PubMed ID: 26887047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDR activation in astrocytic neoplasms.
    Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
    Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.